Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| 10 Jan 2020 |
| Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 6 Jan 2020 |
| Bavarian Nordic Issues Warrants to Newly Appointed Member of the Executive Management | 6 Jan 2020 |
| Bavarian Nordic Announces Closing of Acquisition of Rabipur/RabAvert and Encepur from GlaxoSmithKline and Updates Year-end Cash Preparedness | 31 Dec 2019 |
| Bavarian Nordic Announces the Sale of Priority Review Voucher | 17 Dec 2019 |